Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56


Distinct biological roles for the akt family in mammary tumor progression.

Dillon RL, Muller WJ.

Cancer Res. 2010 Jun 1;70(11):4260-4. doi: 10.1158/0008-5472.CAN-10-0266. Epub 2010 Apr 27. Review.


Mouse models for breast cancer metastasis.

Kim IS, Baek SH.

Biochem Biophys Res Commun. 2010 Apr 9;394(3):443-7. doi: 10.1016/j.bbrc.2010.03.070. Epub 2010 Mar 15. Review.


Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals.

Stecca B, Ruiz I Altaba A.

J Mol Cell Biol. 2010 Apr;2(2):84-95. doi: 10.1093/jmcb/mjp052. Epub 2010 Jan 17. Review.


Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.

Xu L, Kwon YJ, Frolova N, Steg AD, Yuan K, Johnson MR, Grizzle WE, Desmond RA, Frost AR.

Breast Cancer Res Treat. 2010 Aug;123(1):59-71. doi: 10.1007/s10549-009-0617-5. Epub 2009 Nov 10.


Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA.

Noubissi FK, Goswami S, Sanek NA, Kawakami K, Minamoto T, Moser A, Grinblat Y, Spiegelman VS.

Cancer Res. 2009 Nov 15;69(22):8572-8. doi: 10.1158/0008-5472.CAN-09-1500. Epub 2009 Nov 3.


Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Aug 25;9:298. doi: 10.1186/1471-2407-9-298.


Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade.

Hyman JM, Firestone AJ, Heine VM, Zhao Y, Ocasio CA, Han K, Sun M, Rack PG, Sinha S, Wu JJ, Solow-Cordero DE, Jiang J, Rowitch DH, Chen JK.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14132-7. doi: 10.1073/pnas.0907134106. Epub 2009 Aug 5.


The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin.

Das S, Harris LG, Metge BJ, Liu S, Riker AI, Samant RS, Shevde LA.

J Biol Chem. 2009 Aug 21;284(34):22888-97. doi: 10.1074/jbc.M109.021949. Epub 2009 Jun 25.


MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?

Chambers AF.

Cancer Res. 2009 Jul 1;69(13):5292-3. doi: 10.1158/0008-5472.CAN-09-1528. Epub 2009 Jun 23.


Development of mammary tumors by conditional expression of GLI1.

Fiaschi M, Rozell B, Bergström A, Toftgård R.

Cancer Res. 2009 Jun 1;69(11):4810-7. doi: 10.1158/0008-5472.CAN-08-3938. Epub 2009 May 19.


The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer.

Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, Sato N, Kubo M, Kuroki S, Tanaka M, Katano M.

Anticancer Res. 2009 Mar;29(3):871-9.


GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.

Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernández-Zapico ME, Hanahan D.

Genes Dev. 2009 Jan 1;23(1):24-36. doi: 10.1101/gad.1753809.


Triple-negative/basal-like breast cancer: review.

Rakha EA, Ellis IO.

Pathology. 2009 Jan;41(1):40-7. doi: 10.1080/00313020802563510. Review.


Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.

Motrescu ER, Rio MC.

Biol Chem. 2008 Aug;389(8):1037-41. doi: 10.1515/BC.2008.110. Review.


Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.

Martin MD, Carter KJ, Jean-Philippe SR, Chang M, Mobashery S, Thiolloy S, Lynch CC, Matrisian LM, Fingleton B.

Cancer Res. 2008 Aug 1;68(15):6251-9. doi: 10.1158/0008-5472.CAN-08-0537.


Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions.

Motrescu ER, Blaise S, Etique N, Messaddeq N, Chenard MP, Stoll I, Tomasetto C, Rio MC.

Oncogene. 2008 Oct 23;27(49):6347-55. doi: 10.1038/onc.2008.218. Epub 2008 Jul 14.


Primers on molecular pathways GLI: more than just Hedgehog?

Fernández-Zapico ME.

Pancreatology. 2008;8(3):227-9. doi: 10.1159/000134271. Epub 2008 May 22. Review.


Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.

Nagai S, Nakamura M, Yanai K, Wada J, Akiyoshi T, Nakashima H, Ohuchida K, Sato N, Tanaka M, Katano M.

Cancer Sci. 2008 Jul;99(7):1377-84. doi: 10.1111/j.1349-7006.2008.00822.x. Epub 2008 Apr 11.


SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.

Olmeda D, Moreno-Bueno G, Flores JM, Fabra A, Portillo F, Cano A.

Cancer Res. 2007 Dec 15;67(24):11721-31. Erratum in: Cancer Res. 2008 Feb 1;68(3):956.

Supplemental Content

Support Center